Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma

Name: Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma
Published: 2004
License: Public Domain

GlaxoSmithKline · 2004

ClinicalTrials.gov · Datasets · License: Public Domain · 2004

Open Source ↗

lymphoma

lymphoma, non-hodgkin, rituximab, tositumomab and iodine i 131 tositumomab, non-hodgkins lymphoma, radioimmunotherapy, anti-b1 antibody, bexxar, nhl, tositumomab, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma

Related documents